Quantcast
Channel: Latest Crohn's Disease News on BioPortfolio
Viewing all articles
Browse latest Browse all 2985

InDex Pharmaceuticals AB INDEX Financial and Strategic SWOT Analysis Review Report Updated 07082017 Prices from USD $300

$
0
0
SummaryInDex Pharmaceuticals AB InDex Pharmaceuticals is a biopharmaceutical company that provides immunological disease treatments. The company offers Kappaproct which is in Phase III clinical trials for the treatment of refractory ulcerative colitis. Its...

Viewing all articles
Browse latest Browse all 2985

Trending Articles